Search
Elanco Animal Health Inc
ELANAdd to Watchlist
24.245USD
+0.285+1.19%
Market hours （ET）Quotes delayed by 15 min
12.05BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+1.19%
5 Days
+3.66%
1 Month
+11.58%
6 Months
+8.34%
Year to Date
+7.14%
1 Year
+79.46%
Key Figures
24.160Open
24.600High
1.10MVolume
LossP/E TTM
19.45P/E Dynamic
--Dividend TTM
0.22%Turnover Ratio
23.960Prev. Close
24.160Low
17.64MTurnover
35.65P/E Static
1.84P/B
0.00%Div Yield TTM
-1.85%ROA
27.72052wk High
0.36Volume Ratio
338.00MNet Profit
496.98MShares
-0.4882EPS TTM
1.70Beta
-3.77%ROE
13.09052wk Low
1.84%Amplitude
47.19%Gross Margin
12.05BMarket Cap
2.06Reward/Risk
2.43%Risk Rate
TradingKey Stock Score of Elanco Animal Health Inc
Currency: USD Updated: 2026-06-24Key Insights
Elanco Animal Health Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 25 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 30.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Elanco Animal Health Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Elanco Animal Health Inc Highlights
StrengthsRisks
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Undervalued
The company’s latest PE is -49.08, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 549.30M shares, decreasing 9.86% quarter-over-quarter.
Held by Brandes Investmen
Star Investor Brandes Investmen holds 2.81M shares of this stock.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
30.000
Target Price
+23.86%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Elanco Animal Health Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Elanco Animal Health Inc Info
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Ticker SymbolELAN
CompanyElanco Animal Health Inc
CEOSimmons (Jeffrey N)
Websitehttps://www.elanco.com/
Related Instruments
+1.22%
+1.44%
+1.27%
+3.01%
+2.74%
+1.55%
+1.16%
+0.47%
-0.42%
-0.13%
+1.58%
+1.39%
+2.20%
+1.48%
+1.16%
0.00%
+0.42%
+0.76%
+4.25%
-0.51%Popular Instruments
52060.600
+88.900 (+0.17%)
29379.500
-414.700 (-1.39%)
7352.500
-57.900 (-0.78%)
15738.000
+201.000 (+1.29%)
71190.000
+233.000 (+0.33%)
6269.200
+41.000 (+0.66%)
71.394
+1.635 (+2.34%)
274.660
-18.420 (-6.29%)
195.573
-3.427 (-1.72%)
4029.250
+30.510 (+0.76%)
FAQs
What is the current price of Elanco Animal Health Inc (ELAN)?
The current price of Elanco Animal Health Inc (ELAN) is 23.97.
What is the symbol of Elanco Animal Health Inc?
The ticker symbol of Elanco Animal Health Inc is ELAN.
What is the 52-week high of Elanco Animal Health Inc?
The 52-week high of Elanco Animal Health Inc is 27.72.
What is the 52-week low of Elanco Animal Health Inc?
The 52-week low of Elanco Animal Health Inc is 13.09.
What is the market capitalization of Elanco Animal Health Inc?
The market capitalization of Elanco Animal Health Inc is 11.97B.
Is Elanco Animal Health Inc (ELAN) currently rated as Buy, Hold, or Sell?
According to analysts, Elanco Animal Health Inc (ELAN) has an overall rating of Buy, with a price target of 30.00.
What is the Earnings Per Share (EPS TTM) of Elanco Animal Health Inc (ELAN)?
The Earnings Per Share (EPS TTM) of Elanco Animal Health Inc (ELAN) is -0.47.
